Center for Transformative Infectious Disease Research (CTIDR)
Funded at Cornell University · NIH-11421463 · Data updated 2026-11-12
A research center in Cornell aims to understand how weather, animals, people, and pathogens come together to cause infectious disease outbreaks, with plans to build better predictive models and prevention tools.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,180,541 |
| NIH project number | 5P20AI186093-03 |
| Project ID | NIH-11421463 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal for communities at risk of vector-borne diseases or zoonotic spillovers, including populations in areas with variable weather and malaria risk.
✕Less likely to help
People in locations without significant outbreak risk or where data collection is not feasible may see limited direct benefit.
What this research studies
This project brings together researchers to study how climate, vector biology, animal reservoirs, and human behavior influence emerging infectious diseases. It uses community engagement, data from humans and animals, weather patterns, and genomic information to build predictive models for outbreaks and test preventative strategies. The center emphasizes collaboration across disciplines and building capacity for future research and rapid response. It seeks to shift from reacting to outbreaks to predicting and preventing them before they spread.
Why it matters
Potential benefit: Could lead to earlier warnings and stronger preventive measures for vector-borne and zoonotic infections affecting communities.
How similar studies have gone: Previous work shows that integrated social, environmental, and genomic data can improve outbreak forecasting, but this program aims to advance predictive models further.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Travis, Alexander J — Cornell University
- Study coordinator: Travis, Alexander J
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.